These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21076448)

  • 1. Comments on KDIGO clinical practice guidelines for bisphosphonate treatment of chronic kidney disease.
    Przedlacki J
    Kidney Int; 2010 Dec; 78(11):1186; author reply 1186. PubMed ID: 21076448
    [No Abstract]   [Full Text] [Related]  

  • 2. KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease.
    Woo KT; Chan CM
    Kidney Int; 2011 Sep; 80(5):553-4; author reply 554. PubMed ID: 21841837
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic bone diseases: benefits and risks of the treatment].
    Rizzoli R
    Rev Med Suisse; 2009 Jun; 5(207):1299-300. PubMed ID: 19626928
    [No Abstract]   [Full Text] [Related]  

  • 4. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple myeloma].
    Abe M
    Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonate treatment against breast cancer with bone metastases].
    Kohno N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():575-81. PubMed ID: 17682213
    [No Abstract]   [Full Text] [Related]  

  • 7. Sowing the soil for cure? Results of the ABCSG-12 trial open a new chapter in the evolving adjuvant bisphosphonate story in early breast cancer.
    Bedard PL; Body JJ; Piccart-Gebhart MJ
    J Clin Oncol; 2009 Sep; 27(25):4043-6. PubMed ID: 19652062
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapeutic management of osteoprosis and osteopenia.
    Alexander IM
    Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia.
    Cure E; Yuce S; Cure MC
    Minerva Endocrinol; 2013 Jun; 38(2):217-8. PubMed ID: 23732377
    [No Abstract]   [Full Text] [Related]  

  • 10. How effective is bisphosphonate treatment for preventing bone fractures after liver transplantation?
    Hay JE
    Nat Clin Pract Gastroenterol Hepatol; 2008 Apr; 5(4):190-1. PubMed ID: 18268522
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.
    Hodsman A; ; Papaioannou A; ; Ann Cranney ;
    CMAJ; 2006 Jul; 175(1):48. PubMed ID: 16818909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary osteoporosis UPDATE. Bone disease with decreased kidney function].
    Okuno S; Ishimura E
    Clin Calcium; 2010 May; 20(5):655-62. PubMed ID: 20445276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising bisphosphonate treatment outcomes in postmenopausal osteoporosis: review and Italian experience.
    Rossini M; Di Munno O; Gatti D; Giannini S; Minisola S; Varenna M; Adami S
    Clin Exp Rheumatol; 2011; 29(4):728-35. PubMed ID: 21813068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [When should bisphosphonate treatment be discontinued?].
    Eriksen EF; Halse J
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
    [No Abstract]   [Full Text] [Related]  

  • 17. [New development in bisphosphonate treatment. Treatment with bisphosphonates for cancer-induced bone disease].
    Abe M
    Clin Calcium; 2009 Jan; 19(1):55-62. PubMed ID: 19122265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in men.
    Joy M
    N Engl J Med; 2008 Aug; 359(8):868; author reply 869. PubMed ID: 18724403
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonate use in children with bone disease.
    Hickey J; Lemons D; Waber P; Seikaly MG
    J Am Acad Orthop Surg; 2006 Nov; 14(12):638-44. PubMed ID: 17077335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.